🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yunan Nie

Yale University

ORCID: 0000-0002-3136-3483

Also affiliated with University of Colorado Anschutz Medical Campus

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Response to Immune Checkpoint Inhibition as Monotherapy or in Combination With Chemotherapy in Metastatic ROS1-Rearranged Lung Cancers”.

Response to Immune Checkpoint Inhibition as Monotherapy or in Combination With Chemotherapy in Metastatic ROS1-Rearranged Lung Cancers

JTO Clinical and Research Reports(2021)10.1016/j.jtocrr.2021.100187
N/A
0DataRank · unranked
33 citations

Jaime L. Schneider, Tejas Patil, Viola W. Zhu, Debra A. Goldman, Soo-Ryum Yang +13 more

Case Report: Significant Clinical Benefit From Pemetrexed-Based Therapy in ROS1- and ALK-rearranged Lung Cancer With Adenosquamous Histology

Frontiers in Oncology(2022)10.3389/fonc.2021.788245
N/A
0DataRank · unranked
6 citations

Yunan Nie, Dara L. Aisner, David Ross Camidge, Tejas Patil

Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2024.01.012
N/A
0DataRank · unranked
42 citations

So Yeon Kim, Jacqueline V. Aredo, Jamie Feng, Frances A. Shepherd, Chao Xu +52 more

The efficacy of continuing osimertinib with platinum pemetrexed chemotherapy upon progression in patients with metastatic non-small cell lung cancer harboring sensitizing EGFR mutations

Lung Cancer(2024)10.1016/j.lungcan.2024.108040
N/A
0DataRank · unranked
10 citations

Dexiang Gao, Alexander Watson, M Sakamoto, Yunan Nie, A.J. Gibson +13 more

The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLC

JTO Clinical and Research Reports(2024)10.1016/j.jtocrr.2024.100637
N/A
0DataRank · unranked
8 citations

Alyse Staley, Yunan Nie, M Sakamoto, Margaret Stalker, James Jurica +17 more

Perturbational single-cell RNA sequencing of patient tumors in Merkel cell and small cell lung carcinomas.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.2520
N/A
0DataRank · unranked
0 citations

Alexander Frey, Yuewei Fei, Philippos Apolinário Costa, Jason Z Wang, Sina Ghadermarzi +11 more